Clinical trials: Uremic Pruritis
Uremic Pruritus
AST-120 in Hemodialysis Patients With Uremic Pruritus
The prevalence of cutaneous pruritus among hemodialysis patients is about 50% to 80%. There is only a handful of studies on the itchy skin of hemodialysis patients and the findings are to be validated.
- Trial name
- AST-120 (NCT04639674)
- Testing
- AST-120
- Where
- 7 sites in Taiwan
- Volunteers
- 100 people
- Sponsor
- Conmed Pharmaceutical & Bio-Medical Corporation
Renal Insufficiency, Chronic
Montelukast for Treatment of Uremic Pruritus
In this study hemodialysis patients that underwent dialysis thrice weekly screen for uremic pruritus and 80 patients that at least have refractive pruritus that lead to sleep and daily activity disorders enroll in this study.
- Trial name
- NCT02559388
- Testing
- Montelukast
- Volunteers
- 73 people
- Sponsor
- Shiraz University of Medical Sciences
Pruritus, Uremia
Gabapentin - A Solution to Uremic Pruritus?
To investigate using the drug gabapentin to relieve the intense pruritic sensation associated with chronic renal failure patients undergoing peritoneal dialysis.
- Trial name
- NCT00577967
- Testing
- Gabapentin
- Where
- China
- Volunteers
- 80 people
- Sponsor
- Hospital Authority, Hong Kong